Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
04:14p CAMBIAN : Pudsey Bear proves silence is golden
04:14p ATCOR MEDICAL : New U.S. Blood Pressure Guidelines Highlight the Need for Individualization of Care
04:11p MEDTRONIC : profit fell 7 percent after natural disasters affected plants in Puerto Rico, California
04:09p KANCERA : performs the second partial payment for the Fractalkine project
04:09p NAMASTE TECHNOLOGIES : Provides Corporate Update On Cannmart And MD
04:06p CANOPY GROWTH CORPORATION : - New Collaboration Joins Three of the World's Most Influential Cannabis Businesses
04:01p AMN HEALTHCARE SERVICES : Awarded Two Additional Sole-Source Contracts with Premier
03:59p ABLYNX : 21/11/2017 results from the phase iii hercules study of caplacizumab for the treatment of acquired ttp selected for presentation in the late-breaking abstracts session at the 2017 ash annual meeting
03:53p TWO SLUMPING BIOTECH STOCKS COULD BOUNCE BACK : Acadia (ACAD) and Acorda Therapeutics (ACOR)
03:49p AD HOC-RELEASE ACCORDING §15 WPHG : Provision for a debtor warrant in the amount of EUR 19.5 mill. due to a received rent deductions in 2005 to 2007 burden FY 2017 results
03:41p ABLYNX : Results from the phase iii hercules study of caplacizumab for the treatment of acquired ttp selected for presentation in the late-breaking abstracts session at the 2017 ash annual meeting
03:40p PFIZER : NCCN, in Collaboration With Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care
03:40p MEDICLIN AG : Provision for a debtor warrant in the amount of EUR 19.5 mill. due to a received rent deductions in 2005 to 2007 burden FY 2017 results
03:36p CANOPY GROWTH : Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
03:35p GENMAB : Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology
03:34p MOLECULAR PHARMACOLOGY USA : Issues Seven Research Articles in Dec. 1, 2017, Edition
03:34p GLAXOSMITHKLINE : GSK publishes 2018 dividend dates
03:34p ABBVIE : Phase 3 MURANO Study of Venetoclax Chosen as Late-Breaking Abstract at the 2017 American Society of Hematology Annual Meeting & Exposition, Highlighting AbbVie's Commitment to Helping Blood Cancer Patients
03:32p Shire appoints Thomas Dittrich as CFO
03:31p MEDICLINIC INTERNATIONAL : Vontobel Asset Management Inc. - Form 8.3 - Medi-Clinic Corp.Ltd.
03:19p HORIZON DISCOVERY : Structural Multiplex Reference Standard now available in FFPE
03:18p MEDICINE MAN TECHNOLOGIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
03:05p NOVARTIS : Drug Tasigna (Nilotinib) Secures EU Approval for First and Second-Line Treatment of Ph+ CML-CP in Children
03:05p EISAI : Receives IT Business Award for Medication Administration Support Device E - Okusuri - San Equipped With Functions to Support Looking After Patients
03:05p ROCHE : FDA approves Roche's Hemlibra for haemophilia A with inhibitors
03:05p AXOGEN, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
03:05p SAGE THERAPEUTICS : Announces Closing of $345 Million Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
03:05p ARCA BIOPHARMA : Announces Issuance of European Patent for Treating Cardiovascular Diseases
03:05p MERCK : EMD Serono Named 'Top Place to Work' by The Boston Globe for Second Consecutive Year
03:05p CERECOR : Announces Leadership Changes
03:05p CAN FITE BIOPHARMA : Fite's Former Subsidiary OphthaliX Successfully Completes Merger with Wize Pharma
03:05p ASCENDIS PHARMA A/S : AS Reports Third Quarter 2017 Financial Results
03:05p MIMEDX : Market Leadership Well Positioned In Light Of FDA New Guidance Document
03:05p H LUNDBECK : Transactions with shares and linked securities in H. Lundbeck AS made by executives and their closely associated parties
03:05p MERCK : EMD Serono, Inc. - Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe
03:05p GENESIS HEALTHCARE : Genmab Achieves USD 50 Million Sales milestone in DARZALEX Collaboration with Janssen
03:05p CERECOR : Acquires TRx Pharmaceuticals
03:05p AMPIO PHARMACEUTICALS : Announces Continued Listing Plan Accepted by NYSE American
03:05p PFIZER : sponsors 'superbugs' with London's Science Museum
03:05p CELLDEX THERAPEUTICS : Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma
03:04p MEDICURE : Announces Repayment of Outstanding Debt
03:04p INDEX PHARMACEUTICALS : announces Nomination Committee and financial reporting dates for 2018
03:04p EISAI : Antiepileptic drug fycompa regularly available again in germany from december
03:04p HANSA MEDICAL : Nomination Committee for the AGM 2018 appointed
03:04p ROCHE : FDA Approves Genentech's Gazyva for Previously Untreated Advanced Follicular Lymphoma
03:04p MERCK KGAA : Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe
03:04p AGIOS PHARMACEUTICALS : Presents Updated Phase 1 Data from Dose Expansion Cohort of Ivosidenib in Patients with IDH1 Mutant Positive Glioma
03:04p MITHRA PHARMACEUTICALS : Announces Positive Outcome of Myring Commercial Batch Bioequivalence Study
03:04p ROCHE : FDA Approves Genentech's Hemlibra for Hemophilia A with Inhibitors
03:04p AMPIO PHARMACEUTICALS : Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of n in Severe Osteoarthritis of the Knee
03:04p TAKEDA PHARMACEUTICAL : The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. a Top Place to Work for 2017
03:04p AEQUUS PHARMACEUTICALS : Granted European Patent for Once-Weekly Transdermal Aripiprazole
03:04p GRIFOLS : FDA approval of genetic test for alpha-1 deficiency and EMA approval of fibrin sealant
03:04p LIPOCINE INC. : - U.S. FDA Extends Review for TLANDO Advisory Committee Meeting Date of January 10 2018 Remains Unchanged
03:03p ACADIA PHARMACEUTICALS : to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28, 2017
03:03p PATTERSON COMPANIES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
03:02p CHUGAI PHARMACEUTICAL : HEMLIBRA Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors
03:02p OTSUKA : Taiho Pharmaceutical Head Office to Temporarily Relocate
03:01p INFINITY PHARMACEUTICALS : Global Biotechnology Market Showing Potential for Further Growth
03:01p ZYNERBA PHARMACEUTICALS : Announces Poster Presentation at the 2017 Annual Meeting of the American Epilepsy Society (AES)
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement